Please assess the completion status of the following clinical trial:

Trial Title: Skin and Blood Research Samples From Healthy Volunteers and Patients With Hematologic Diseases

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18.~* No active systemic skin infection at biopsy site.~* No allergy to lidocaine or other local anesthetics~Exclusion Criteria:~ALL PATIENTS~* History of a bleeding disorder, easy bleeding, or bruising.~* Inability or unwillingness to provide informed consent.~SICKLE CELL PATIENTS~* Platelets ≤ 50,000~* INR ≥ 1.5~* Currently bing given intravenous heparin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Healthy Volunteers (Type: OTHER): To obtain a one time skin sample (4 ml skin punch biopsy) and one time blood sample (1 teaspoon)
- Patients with benign, inherited hematologic disease (Type: OTHER): To obtain a one time skin sample (4 ml skin punch biopsy) and one time blood sample (1 teaspoon)

Based on this trial design, predict the completion outcome and termination type (if applicable).